Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs

Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Transcript
Novo Nordisk is out with results this morning now lowering its fullear profit uh and revenue uh forecast. Meanwhile, uh the company it's it's getting very interesting in terms uh of uh this possible uh bidding war uh that uh that we are seeing as we move that up a little bit please. That's what this means. Yeah, there you go. Keep going. Keep going... Read More
Install to Summarize YouTube Videos and Get Transcripts
Explore YouTube Video Summarizer or Get YouTube Transcript Extractor
Read in Other Languages (beta)
Share This Summary 📚
Summarize YouTube Videos and Get Video Transcripts with 1-Click
Download browser extensions on:
Try YouTube Summary with ChatGPT & Claude or YouTube Transcript Generator
Explore More Summaries from CNBC Television 📚

Private payrolls rose 42,000 in October, more than expected and countering labor market fears: ADP
CNBC Television

BlackRock files application with SEC for staked ether ETF: CNBC Crypto World
CNBC Television

Difficult to build rationale to lower rates at this point, says former Minneapolis Fed president
CNBC Television

Sara Nelson on record Thanksgiving travel: In the best position possible going into this holiday
CNBC Television

How to fix AI sales problems, says Palantir CEO
CNBC Television

The reopening rally: Here's what you need to know
CNBC Television
Summarize YouTube Videos and Get Video Transcripts with 1-Click
Download browser extensions on:
Try YouTube Summary with ChatGPT & Claude or YouTube Transcript Generator